Comparison of four commercially available assays for the detection of IgM phase II antibodies to Coxiella burnetii in the diagnosis of acute Q fever

Dimitrios Frangoulidis; Elmar Schröpfer; Sascha Al Dahouk; Herbert Tomaso; Hermann Meyer

doi:10.1196/annals.1374.110

Comparison of four commercially available assays for the detection of IgM phase II antibodies to Coxiella burnetii in the diagnosis of acute Q fever

Ann N Y Acad Sci. 2006 Oct:1078:561-2. doi: 10.1196/annals.1374.110.

Authors

Dimitrios Frangoulidis¹, Elmar Schröpfer, Sascha Al Dahouk, Herbert Tomaso, Hermann Meyer

Affiliation

¹ Bundeswehr Institute of Microbiology, Neuherbergstr. 11, 80937 Munich, Germany. DimitriosFrangoulidis@Bundeswehr.org

PMID: 17114777
DOI: 10.1196/annals.1374.110

Abstract

Four commercially available serological assays for the detection of IgM phase II antibodies in patients with acute Q fever infection were compared using a panel of 23 serum samples from patients with acute Q fever and 88 control sera from blood donors.

MeSH terms

Acute Disease
Antibodies, Bacterial / blood*
Coxiella burnetii / immunology
Coxiella burnetii / isolation & purification*
Humans
Immunoglobulin M / blood*
Q Fever / blood
Q Fever / diagnosis*
Q Fever / immunology*
Sensitivity and Specificity

Substances

Antibodies, Bacterial
Immunoglobulin M